Literature DB >> 17174761

Bite force and maxillofacial morphology in patients with Duchenne-type muscular dystrophy.

Koichiro Ueki1, Kiyomasa Nakagawa, Etsuhide Yamamoto.   

Abstract

PURPOSE: The purpose of this study is to evaluate maxillofacial morphology and bite force in patients with severe Duchenne-type myodystrophy. PATIENTS AND METHODS: The subjects included 24 men (average age, 21.5 years; range, 17 to 30 years) with Duchenne-type muscular dystrophy receiving treatment in National Ioh Hospital. Lateral and axial cephalograms were used to assess the morphology in this study. The maximum bite force on the first molar and the maximum mouth opening distance were measured.
RESULTS: The anterior open bite was visualized in most patients on the lateral cephalogram. The upper and lower arch lengths in the patients were significantly smaller than those in the controls (P < .05). In contrast, the upper and lower arch widths in the patients were significantly larger than those in the controls (P < .05). The maximum bite force and maximum mouth opening distance in the patients were significantly lower than those in the controls (P < .05).
CONCLUSION: These results appear to be very useful for improving the care and treatment of patients with Duchenne-type muscular dystrophy.

Entities:  

Mesh:

Year:  2007        PMID: 17174761     DOI: 10.1016/j.joms.2005.11.108

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  7 in total

1.  Effects of enzyme replacement therapy on five patients with advanced late-onset glycogen storage disease type II: a 2-year follow-up study.

Authors:  Yoshihiko Furusawa; Madoka Mori-Yoshimura; Toshiyuki Yamamoto; Chikako Sakamoto; Mizuki Wakita; Yoko Kobayashi; Yutaka Fukumoto; Yasushi Oya; Tokiko Fukuda; Hideo Sugie; Yukiko K Hayashi; Ichizo Nishino; Ikuya Nonaka; Miho Murata
Journal:  J Inherit Metab Dis       Date:  2011-10-07       Impact factor: 4.982

2.  Consensus statement on standard of care for congenital myopathies.

Authors:  Ching H Wang; James J Dowling; Kathryn North; Mary K Schroth; Thomas Sejersen; Frederic Shapiro; Jonathan Bellini; Hali Weiss; Marc Guillet; Kimberly Amburgey; Susan Apkon; Enrico Bertini; Carsten Bonnemann; Nigel Clarke; Anne M Connolly; Brigitte Estournet-Mathiaud; Dominic Fitzgerald; Julaine M Florence; Richard Gee; Juliana Gurgel-Giannetti; Allan M Glanzman; Brittany Hofmeister; Heinz Jungbluth; Anastassios C Koumbourlis; Nigel G Laing; Marion Main; Leslie A Morrison; Craig Munns; Kristy Rose; Pamela M Schuler; Caroline Sewry; Kari Storhaug; Mariz Vainzof; Nanci Yuan
Journal:  J Child Neurol       Date:  2012-03       Impact factor: 1.987

3.  A qualitative engineering analysis of occlusion effects on mandibular fracture repair mechanics.

Authors:  Thomas R Katona
Journal:  J Dent Biomech       Date:  2011-09-29

4.  Range of motion exercise of temporo-mandibular joint with hot pack increases occlusal force in patients with Duchenne muscular dystrophy.

Authors:  S Nozaki; M Kawai; R Shimoyama; N Futamura; T Matsumura; K Adachi; Y Kikuchi
Journal:  Acta Myol       Date:  2010-12

5.  Orofacial muscles may be affected in early stages of Becker muscular dystrophy: A preliminary study.

Authors:  Marloes L J Lagarde; Nens van Alfen; Alexander C H Geurts; Imelda J M de Groot; Lenie van den Engel-Hoek
Journal:  Muscle Nerve       Date:  2019-12-24       Impact factor: 3.217

6.  Growth curves for mandibular range of motion and maximum voluntary bite force in healthy children.

Authors:  Daan R C Verkouteren; Willemijn F C de Sonnaville; Nicolaas P A Zuithoff; Nico M Wulffraat; Michel H Steenks; Antoine J W P Rosenberg
Journal:  Eur J Oral Sci       Date:  2022-04-28       Impact factor: 2.160

7.  Influence of full-length dystrophin on brain volumes in mouse models of Duchenne muscular dystrophy.

Authors:  Bauke Kogelman; Artem Khmelinskii; Ingrid Verhaart; Laura van Vliet; Diewertje I Bink; Annemieke Aartsma-Rus; Maaike van Putten; Louise van der Weerd
Journal:  PLoS One       Date:  2018-03-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.